Table 1. Clinicopathological characteristics of the lung adenocarcinomas (n = 72).
| Variables | N (%) |
|---|---|
| Sex | |
| Male | 41 (56.9%) |
| Female | 31 (43.1%) |
| Age | |
| median (range) | 63 (30-80) |
| Smoking status | |
| Never | 35 (48.6%) |
| Ever | 37 (51.4%) |
| Tumor size | |
| ≤3cm | 36 (50%) |
| >3cm | 36 (50%) |
| Pleural invasion | |
| Absent | 37 (51.4%) |
| Present | 35 (48.6%) |
| Vascular invasion | |
| Absent | 43 (59.7%) |
| Present | 29 (40.3%) |
| Lymphatic invasion | |
| Absent | 29 (40.3%) |
| Present | 43 (59.7%) |
| Pathologic stage | |
| I | 32 (44.4%) |
| II | 19 (26.4%) |
| III | 17 (23.6%) |
| IV | 4 (5.6%) |
| Genetic status | |
| ALK- rearranged | 16 (22.2%) |
| EGFR-mutated | 19 (26.4%) |
| KRAS-mutated | 17 (23.6%) |
| Triple negative | 20 (27.8%) |